Insider Buying: Johnson Matthey (LON:JMAT) Insider Buys £249.48 in Stock

Johnson Matthey PLC (LON:JMATGet Free Report) insider Liam Condon acquired 12 shares of the business’s stock in a transaction dated Friday, October 10th. The shares were bought at an average cost of GBX 2,079 per share, for a total transaction of £249.48.

Liam Condon also recently made the following trade(s):

  • On Tuesday, August 12th, Liam Condon bought 14 shares of Johnson Matthey stock. The stock was bought at an average price of GBX 1,773 per share, with a total value of £248.22.

Johnson Matthey Price Performance

Shares of LON JMAT opened at GBX 2,156 on Thursday. The stock’s 50-day moving average is GBX 1,935.24 and its two-hundred day moving average is GBX 1,689.40. The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76. Johnson Matthey PLC has a 1-year low of GBX 1,131 and a 1-year high of GBX 2,188. The company has a market cap of £3.61 billion, a price-to-earnings ratio of 1,020.83, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95.

Analysts Set New Price Targets

JMAT has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the stock a “buy” rating in a research report on Thursday, October 9th. Berenberg Bank lifted their price target on Johnson Matthey from GBX 1,950 to GBX 2,100 and gave the stock a “hold” rating in a report on Thursday, October 9th. Finally, Jefferies Financial Group increased their price objective on Johnson Matthey from GBX 2,200 to GBX 2,420 and gave the company a “buy” rating in a report on Tuesday. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of GBX 2,273.33.

Get Our Latest Stock Report on Johnson Matthey

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Further Reading

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.